Outsourcing

Beyond Sterile

The Quiet Complexity of Non-Sterile Outsourcing

Discussions about pressure points in pharmaceutical manufacturing tend to move quickly to sterile injectables

CDMOs in a High-Demand, Low-Capacity Sterile Outsourcing Landscape

The sterile drug outsourcing segment in the pharmaceutical industry undergoes a significant change

Fill Finish Shift in Innovation, Agility, and the Path to Patient-Centric Pharma

The end process between pharmaceutical innovation and patient healthcare management in the highrisk